江蘇年底前執行國家藥品集中採購試點擴圍結果 25種藥品擬平均降價59%
據《新華日報》報道,江蘇省醫保局等九部門近日聯合印發《江蘇省推進落實國家組織藥品集中採購和使用試點擴大區域範圍工作實施方案》,明確今年底前全面執行國家試點擴圍結果和各項配套政策。據測算,此輪採購中選的25種藥品在江蘇落地後平均降價59%,年節約資金26億元人民幣。
據了解,參與此次藥品降價的機構包括:省內所有公立醫療機構、參加試點擴圍的軍隊醫療機構和自願參加試點擴圍的醫保定點社會辦醫療機構、醫保定點零售藥店。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.